XPHYF News and Press, XPhyto Therapeutics Corp From 10/19/20

VANCOUVER, BC / ACCESSWIRE / October 19, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY / OTCQB:XPHYF / FSE:4XT ) (" XPhyto " or the " Company "), a next-generation bioscience company, is pleased to announce an update on its third-party contract development programs. Over the past 12 month...

Click here to read the previous top cannabis stocks year-to-date list. Amid a global pandemic, the cannabis stock market has taken heavy losses as the industry adjusts to developing metrics and the evolution of consumer trends. As the US election draws nearer, expectatio...

VANCOUVER, BC / ACCESSWIRE / September 22, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY) (OTC:XPHYF) (FSE:4XT ) (" XPhyto " or the " Company "), a next-generation bioscience company, is pleased to announce an update on its oral disintegrating film ("ODF") drug delivery programs. XPhyto's...

VANCOUVER, BC / ACCESSWIRE / September 14, 2020 / XPhyto Therapeutics Corp. (CSE:XPHY) (FSE:4XT) (OTCQB:XPHYF) ("XPhyto" or the "Company") is pleased to announce the company will be presenting at the Virtual Life Sciences Forum, hosted by the OTC Markets Group, on September 17 at 1:00 pm Eas...

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com NEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and ind...

Houston, Texas--(Newsfile Corp. - September 9, 2020) - With the pandemic still showing no signs of abating, demand for diagnostic testing has only increased. Unfortunately, the nation is still running into severe diagnostic test shortages, which could hamper the nation's response to the pa...

VANCOUVER, BC / ACCESSWIRE / September 8, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY / OTCQB:XPHYF / FSE:4XT ) (" XPhyto " or the " Company "), a next generation bioscience company, is pleased to announce an update on its rapid COVID-19 (SARS-CoV-2) screening test. XPhyto and its exclu...

Vancouver, British Columbia--(Newsfile Corp. - August 25, 2020) - XPhyto Therapeutics Corp . ( CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT ) (" XPhyto " or the " Company "), a next generation bioscience company, is pleased to announce an update on its transdermal delivery system ("TDS") for the n...

VANCOUVER, BC / ACCESSWIRE / August 14, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY / OTCQB:XPHYF / FSE:4XT ) (" XPhyto " or the " Company "), a next generation bioscience company, is pleased to announce that its common shares are now trading on the OTCQB Venture Market ("OTCQB Venture")...

VANCOUVER, BC / ACCESSWIRE / August 10, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY / OTC PINK:XPHYF / FSE:4XT ) (" XPhyto " or the " Company "), a next generation bioscience company, is pleased to announce an update on its rapid COVID-19 (SARS-COV-2) screening test, near-term milestones...